<DOC>
	<DOCNO>NCT00969072</DOCNO>
	<brief_summary>The primary objective ass safety GI198745 0.05mg , 0.5mg , 2.5mg daily 52 week .</brief_summary>
	<brief_title>Extension Study GI198745 Treat Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>Upon completion 24 week GI198745 0.05 mg , 0.5 mg , 2.5 mg , placebo therapy study ARI20005 , subject enrolled extension phase continue therapy daily 28 week , follow 16 week post-dosing assessment .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Has receive investigational product least 20 week precede dose find study investigator subinvestigator confirm tolerability judge appropriate participate continuously 28 week treatment . Is withdraw dose finding study . Has less 75 % compliance investigational product dose find study give informed consent longterm extension study . Has prostate cancer give informed consent participate longterm extension study ; suspect prostate cancer palpation , ultrasound imaging , biopsy , etc . give informed consent participate longterm extension study . Has post void residual volume &gt; 250 ml start longterm extension study . ( measure suprapubic ultrasound ) . Has chronic bacterial prostatitis chronic urinary tract infection dose find study Has acute urinary retention dose find study . Has history current evidence drug alcohol abuse dose find study Has treat investigational product include postmarketing clinical trial dose find study . Has myocardial infarction , coronary arterial bypass surgery , unstable angina , arrhythmia , congestive heart failure , cerebrovascular accident dose find study . Has concurrent disease complication , opinion investigator/subinvestigator , difficult evaluate efficacy GI198745 study might pose additional risk patient . Is actively try procreate study period . Is unsuitable study , opinion investigator/subinvestigator .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>GI198745</keyword>
	<keyword>Long term extension study</keyword>
	<keyword>BPH</keyword>
</DOC>